[HTML][HTML] Replication-defective virus vaccine-induced protection of mice from genital herpes simplex virus 2 requires CD4 T cells

LA Morrison - Virology, 2008 - Elsevier
LA Morrison
Virology, 2008Elsevier
Replication-defective herpes simplex virus 2 (HSV-2), used as an immunization strategy,
protects against HSV-2 challenge in animal models. The roles of replication-defective virus-
induced T cell subsets in control of HSV-2 infection have not been established. Mice lacking
B cells (µMT) were immunized, depleted of CD4 or CD8 T cells, and then challenged
intravaginally with HSV-2 to elucidate T cell subset contributions in the absence of virus-
specific antibody. Immunized, CD4-depleted µMT mice developed severe infection of the …
Replication-defective herpes simplex virus 2 (HSV-2), used as an immunization strategy, protects against HSV-2 challenge in animal models. The roles of replication-defective virus-induced T cell subsets in control of HSV-2 infection have not been established. Mice lacking B cells (µMT) were immunized, depleted of CD4 or CD8 T cells, and then challenged intravaginally with HSV-2 to elucidate T cell subset contributions in the absence of virus-specific antibody. Immunized, CD4-depleted µMT mice developed severe infection of the genital tract and nervous system. In contrast, depletion of CD8 T cells from µMT mice did not attenuate protection. Immunized wild-type mice depleted of CD4 T cells also developed more severe HSV-2 infection than mice from which CD8 T cells were depleted. Thus, immunization with replication-defective virus induces T cell responses that effectively control HSV-2 infection in the absence of HSV-immune antibody, and CD4 T cells play the predominant role in this protective effect.
Elsevier